Watchlist 6-14-22 & Recap

by · Published · Updated

Hi everyone,

Hope you all had a green Monday in spite of a super bloody market. I buy red on bloody ugly days; I do not allow my emotions to get the best of me. I am confident in the bigger moves, and I will not let anyone sway me away from my convictions. Many of you need to step away from the screen if you’re going to become keyboard warriors. I am all about results, so if my trades become compromised, I will not share my trading plans. I do not get paid for my analysis and research. So, the LEAST you can do is read the disclosures and NOT ask me the same things over and over. Please manage your risks and read the disclosure below before even proceeding to read my trading plans. Whether futures are red or green, we’ll continue to compound those gains and keep our accounts green. May all your accounts continue to be blessed.

Manage Risks / Trading Plan Disclosure / Tips

  1. These are my trading plans, and many ask if I’m holding this or that. If it breaks any of the dip zones that I mention or if it breaks the trend line for a swing on the 5D/30D chart, I will respect my rules and I will respect my stop loss and wait for the setup to re-enter.
  2. It does NOT matter how strong the DD/Catalysts are; if the setup or volume isn’t there; the market won’t care about your feelings when you choose not to respect your trading rules.
  3. In a bear market, POSITION SIZE IS EVERYTHING. Do NOT trade with more than 2-10% of your accounts unless you’re able to CONSISTENTLY make $100/day or 1-2%/day. You are NOT smarter than the market. The market doesn’t care if you blow up your accounts.
  4. Consistency builds good habits. The goal should be to build a strong trader mindset by being systematic, logical, unemotional, and quick to make those executions. Accountability is key; if you blame others for your mistakes; you will NEVER grow and you are setting yourself up for failure.
  5. These are MOSTLY swings (days/weeks/months DEPENDING on volume), so if 1) they do not make any significant moves, 2) news have yet to drop, or 3) they have yet to hit the price targets; that means the swing continues as long as it respects the trend line when swinging and there is VOLUME to drive PRICE ACTION. If one chooses not to respect their mental stop losses, prepare for lower lows.
  6. Never bag hold, never average down on a loser UNLESS you’re confident it will reverse, and never turn a day trade into a swing if you do not have a set plan.
  7. For those under PDT, be careful with setting up swings too early in the day; I prefer waiting until after lunch (EST) to set my swings up (unless it hit my perfect dip zone).
  8. Once the initial dip zone is eaten, respect the trend line on the way up and only accumulate at the pullbacks that respect the trend line. Pulling us back down to the initial dip zone ISN’T a good thing; it only sets us back. The goal is HIGHER LOWS.
  9. During crucial points, when we’re build a bull flag and setting up a short squeeze, those are the times to buy the ASK so we can break the wall down for the next leg.
  10. Selling into the bid LOWERS the stock and kills momentum. There’s nothing wrong with setting sell limits, when scaling out profits, and letting it hit; but when everyone sells into the bid while shorts are shorting, this is what causes stop loss raids, therefore, the stock knifes down.
  11. Always make sure you have a day trade available in case you need to exit and reposition.
  12. It’s okay to be wrong, but it’s not okay to stay wrong. Hope doesn’t make us money; proper risk management does.
  13. Many of these are great long term plays if one was to load up on red days while respecting the trend line for setting up swings. There’s nothing wrong with buying on green days if buying the BIG pullbacks. Best way to get burned is to chase while they’re ripping upward.
  14. If these don’t run yet, and are holding new support levels, especially at my dip zone, assume I’m accumulating, and holding for a bigger move. I mainly set swings up as soon as I see signs of a reversal with anticipation of catalysts. From the original alert, expect my multi-week swings to run at least 100% with pullbacks in-between.
  15. I provide my watchlists for all types of traders. If you’re conservative, consider anything $50 and up; if you have higher risk tolerance, consider penny stocks below $2; if you’re in the middle, consider anything between $2-$50.
  16. When trading large caps, it is normal for it to move ~0.5-6%. When trading mid caps, it is normal for it to move ~5-15%. When trading small caps, it is normal for it to move ~8-30%+. When assessing goals, it’s important to make sure to take in consideration a stock’s volatility and match it to your particular trading style.
  17. SSR triggered setups are my preferred setups for swinging. This does not mean that it cannot be shorted. If the volume is high, price action/momentum is there, with upcoming catalysts; then this is my preferred setup as someone who swings. I keep a mental stop in case I need to reposition my swing. Not every SSR trade will move up; there are many variables one must take into account when trading this type of setup.
  18. DO NOT enter an SSR setup if using hard stops; this RUINS the setup since it’s a bottom play setup; only those accumulating dips to build full positions for the bigger move should consider this type of trade. Hard stops will cause the stock to break CRUCIAL support levels that are needed to be established for the move up.
  19. If the market is red, consider respecting your stop losses. Stopping out doesn’t mean you’re unable to re-enter; it’s you giving yourself the best setup while managing your risks, and maximizing profit potential. Waiting for confirmation is crucial once it hits the dip zones; I would never just jump in and buy. It’s important they hold at the dip zone levels. If it breaks below, I typically wait for it to reclaim that dip zone before scaling in.
  20. I do NOT hold all stocks listed below. I provide a list of top mentions/trending/abnormal volume movers/upcoming catalysts/earnings/conservative large caps. You decide what you trade based on your preference.

6/14/22 Main Watch

Refer to the Setups Recap for the swing setups from previous weeks as most of the catalysts are happening this week.

  1. BLUE
  2. RDBX
  3. IMPP
  4. AUVI
  5. HUSA
  6. COGT
  7. PBTS
  8. TSLA
  9. MULN
  10. AERC

6/13/22 Setups Recap & Trading Plan

BLUE

BLUE 6/10/22 Chart Plan for 6/13/22

I will be buying big pullbacks for the next leg up, and will be setting this up as a multi-day/week swing for as long as there is volume to drive price action. If there is a pullback, dip zone might be at $5.95-$6.30. Once $7 levels are reclaimed, the next leg is $7.75-$8. After that is $8.50-$10. We will walk this up until we break ATH.

BLUE 6/13/22 Chart Plan for 6/14/22

Day’s Volume: 71,473,880

Average 10 Day Volume: 10.78M

Day’s range: $4.23-$6.17

Closing Price: $4.27

Short Interest: 17.84%

Analyst Price Target: High PT: $14, Low PT: $2, Average PT: $7.33

Catalysts:

  • FDA Advisory Committee Unanimously Supports beti-cel Gene Therapy for People with beta-thalassemia Who Require Regular Red Blood Cell Transfusions. 6/10/22. View news here.
  • FDA Advisory Committee Unanimously Endorses eli-cel Gene Therapy for Cerebral Adrenoleukodystrophy. 6/9/22. View news here.
  • bluebird bio stock trading halted today June 9th and tomorrow June 10th. 6/9/22. View news here.
  • bluebird bio Announces Posting of Briefing Documents for Upcoming FDA Advisory Committee Meeting. 6/7/22. View news here.
  • bluebird bio Reports First Quarter 2022 Financial Results and Highlights Operational Progress. 5/9/22. View news here.
  • bluebird bio Initiates Restructuring to Reduce Operating Expenses and Advance Near-term Opportunities to Bring Potentially Curative Gene Therapies to Patients in the US. 4/5/22. View news here.
  • View company pipeline here.

On Thursday, June 9th, the company halted trading of their common stock. It was unhalted after the close on Friday, June 10, 2022. The U.S. Food and Drug Administration’s (FDA) Cellular, Tissue, and Gene Therapies Advisory Committee (CTGTAC) met to “discuss the biologics licensing applications (BLAs) for betibeglogene autotemcel (beti-cel) and elivaldogene autotemcel (eli-cel). Beti-cel is under review for the treatment of people with β-thalassemia who require regular red blood cell transfusions. Eli-cel is under review for the treatment of early active cerebral adrenoleukodystrophy (CALD) in patients less than 18 years of age who do not have an available and willing human leukocyte antigen (HLA)-matched sibling hematopoietic stem cell (HSC) donor.” This has been trending over the last week and ranking #32 in Real-time ranking. With the new FDA advisory committee unanimously endorsing treatment, There should be more catalysts coming following the positive news. I will be watching for Analyst upgrades in the coming weeks.

BLUE broke all support levels and fading into the close, breaking lower after hours. This primarily is due to the whole market being red. If futures opens green, it most likely will not see the lower end of the dip zone. If there is a pullback, dip zone might be at ($3.84-$4.30). $3.84 triggers SSR for an SSR swing setup for Wednesday 6/14/22. $5 levels will need to be reclaimed, then the next leg is $6-$7. After that is $8-$10. We will walk this up until we break ATH. As long as the momentum is there, this can be a good multi-week swing due to the higher short interest (17.84%).

COGT

COGT 6/10/22 Chart Plan for 6/13/22

COGT hit low of day of $5.20 premarket, followed by a press release, “Cogent Biosciences Announces Positive Initial Clinical Data from Ongoing Phase 2 APEX Trial Evaluating Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM).” 6/10/22. View news here. It hit high of day $10.89 intraday, followed by a fade into the close, and closing at $7.87. If there is a pullback, dip zone might be at $6.29-$6.68.

COGT 6/13/22 Chart Plan for 6/14/22

Day’s Volume: 23,831,724

Average 10 Day Volume: 12.19M

Day’s range: $6.90-$10.15

Closing Price: $8.74

Short Interest: 5.11%

Analyst Price Target: High PT: $31, Low PT: $15, Average PT: $20.14

Catalysts:

  • SVB Leerink analyst Andrew Berens maintains Cogent Biosciences with a Outperform and raises the price target from $14 to $15. 6/13/22.
  • Cogent Biosciences Announces Pricing of Upsized Public Offering of Shares of Common Stock and Pre-funded Warrants. 6/13/22. View news here.
  • Cogent Biosciences Announces Proposed Public Offering of Common Stock. 6/13/22. View news here.
  • Cogent Biosciences Announces Positive Initial Clinical Data from Ongoing Phase 2 APEX Trial Evaluating Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM). 6/10/22. View news here.
  • Cogent Biosciences to Host Investor Webcast on June 10, 2022 at 8:00am ET. 6/6/22. View news here.
  • Cogent Biosciences Announces Annual Meeting of Stockholders. 6/2/22. View news here.
  • Cogent Biosciences Announces Presentation at European Hematology Association (EHA) Annual Congress. 5/12/22. View news here.
  • Cogent Biosciences Reports Recent Business Highlights and First Quarter 2022 Financial Results. 5/10/22. View news here.
  • Cogent Biosciences to Participate in the LifeSci Partners Immunology and Inflammation Symposium. 5/6/22. View news here.
  • View company pipeline here.

COGT hit my dip zone ($6.29-$6.68) at $6.45 premarket, followed by a +$3.70 (+57.36%) to high of day $10.15, and closing at $8.74. If there is a pullback, dip zone might be at $7.20-$8.10.

AERC

AERC 6/10/22 Chart Review & Plan for 6/13/22

AERC hit my dip zone ($8.20-$8.50) at $8.34 (✓), moving +$5.36 (+64.27%) to high of day $13.70 intraday, closing at $12.50. If there is a pullback, the dip zone may be at ($10.30-$11.00). We will need to reclaim $12 levels and walk this up one step at a time. We need to form a base at $13 again, and climb up slowly one leg at a time, with healthy pullbacks in-between to break $15 levels. Shorts are going to try to push this down so it’s important that the climb is steady to make it difficult for shorts to short the pops. The goal is to get to $20+ but that all depends on whether all the big pullbacks get bought up or not.

AERC 6/13/22 Chart Review & Plan for 6/14/22

Day’s Volume: 54,086,335

Average 10 Day Volume: 36.68M

Day’s range: $11.44-$18.50

Closing Price: $17.25

Short Interest: 2.28%

Catalysts:

  • AeroClean Announces Appointment of Jimmy Thompson as Vice President of Strategic Sales. 6/8/22. View news here.
  • AeroClean Receives FDA Clearance For Pūrgo™ Medical Grade Air Hygiene Technology. 6/6/22. View news here.
  • AeroClean Provides Resources To Support Government Push for Cleaner, Safer Indoor Air. 5/18/22. View news here.
  • AeroClean Announces Appointment of Timothy J. Scannell to Board of Directors. 5/12/22. View news here.
  • AeroClean Reports First Quarter 2022 Financial Results. 5/12/22. View news here.

AERC hit $0.12 above my dip zone ($10.30-$11.00) at $11.12 (✓), moving +$7.70 (+69.24%) to high of day $18.82 after hours, after closing at $17.25. If there is a pullback, the dip zone may be at ($15.52-$16.25). We will need to claim $19 levels and walk this up past $20 levels. Once a base is formed at $20, and climb up slowly one leg ($1) at a time, with healthy pullbacks in-between to break all time highs. Shorts are going to try to push this down so it’s important that the climb is steady to make it difficult for shorts to short the pops. The goal is to get to $20+ but that all depends on whether all the big pullbacks get bought up or not.

AUVI

AUVI 6/10/22 Chart Review & Plan for 6/13/22

AUVI fell below my dip zone ($2.20-$2.47) to $2.08, triggering SSR for Monday 6/13/22, and reclaimed my dip zone shortly after (✓) intraday, and moved up +$0.78 (+37.5%) to high of day $2.86 intraday, closing at $2.76. If there is a pullback, dip zone may be at ($2.45-$2.60). $3 will need to be reclaimed and walked up to $3.50 levels, and then $4+. The goal is to break $6+ and then all time highs as long as the volume is still there to drive price action.

AUVI 6/13/22 Chart Review & Plan for 6/14/22

Day’s Volume: 17,905,856

Average 10 Day Volume: 17.64M

Day’s range: $2.55-$3.44

Closing Price: $2.69

Short Interest: 2.49%

Analyst PT: High PT: $10.40, Low PT: $2.00, Average PT: $6.20

Catalysts:

  • Tech Leaders: NEXCF, RBLX AUVI, AIMLF; Visionary CEOs Advancing Next Wave of Multi-Billion Dollar Growth Opportunities in Metaverse, HealthTech Wearables, and Clean Air Technologies. 6/9/22. View news here.
  • Applied UV Announces International Dealer Awarded Sole Source Provider Contract for Airocide’s FDA Class II Listed Medical Device. 6/9/22. View news here.
  • Applied UV to Present and Showcase Airocide and Scientific Air Technology at the LD Micro Invitation June 8th, 2022. 5/31/22. View news here.
  • Applied UV Declares Monthly Preferred Stock Dividend. 5/24/22. View news here.
  • Applied UV Adds Veteran Leader and Banking Executive Jos Luhukay to Board of Directors. 5/24/22. View news here.
  • Applied UV Reports 1st Quarter 2022 Results. 5/24/22. View news here.

AUVI hit $0.05 below my dip zone ($2.45-$2.60) $2.40 premarket (✓), and moved up +$1.04 (+43.33%) to high of day $3.44 intraday, closing at $2.69. If there is a pullback, dip zone may be at ($2.60-$2.75). $3 will need to be reclaimed and walked up to $3.50 levels, and then $4+. The goal is to break $6+ and then all time highs as long as the volume is still there to drive price action.

HUSA

HUSA 6/10/22 Chart Review & Plan for 6/13/22

HUSA hit my dip zone ($6.50-$6.75) at $7.02 (✓), and moved +$0.57 (+8.12%) to $7.59 intraday. HUSA then faded to low of day $6.24, triggering SSR for Monday, 6/13. pulling back -17.79%, and closing at $7.10. With crude oil possibly breaking all time highs next week following Father’s Day, I’ll be buying any big pullbacks for the bigger move. HUSA is under SSR tomorrow, so if there is a pullback, possible dip zone might be ($6.50-$6.75).

HUSA 6/13/22 Chart Review & Plan for 6/14/22

Day’s Volume: 15,654,490

Average 10 Day Volume: 26.46M

Day’s range: $6.10-$7.34

Closing Price: $6.30

Short Interest: 12.41%

My twitter post was published in “4 Penny Stocks to Buy Amid High Inflation: HUSA NINE IMPP RIBT” – Insider Financial. 6/12/22. View article here.

Catalysts:

  • 4 Penny Stocks to Buy Amid High Inflation: HUSA NINE IMPP RIBT – Insider Financial. 6/12/22. View article here.
  • Houston American Energy Increases Interest In Colombian Project. 5/31/22. View press release here.
  • Houston American Energy Announces Spudding of First Well on SPO-11 Venus Exploration Area in Colombia. 5/24/22. View press release here.
  • 10-Q Quarterly Filings Ended March 31, 2022. View sec-filing here.
  • 8-K Current Reports. 3/27/22. View sec-filing here.
  • SC 13D Current Reports. 2/2/22. View sec-filing here.

HUSA fell below my dip zone ($6.50-$6.75) at $6.10, triggering SSR again for Tuesday, 6/14, and then it was able to reclaim the dip zone and moved +$1.24 (+20.33%) to $7.34 intraday. HUSA then faded into the close, and closing at $6.30. With crude oil possibly breaking all time highs next week following Father’s Day, I’ll be buying any big pullbacks for the bigger move. HUSA is under SSR tomorrow, so if there is a pullback, possible dip zone might be ($6.50-$6.75).

MF

MF 6/10/22 Chart Review & Plan for 6/13/22

MF hit my dip zone ($0.2750-$0.2850) $0.2676, but did not make any significant moves. $0.30 levels needs to be reclaimed for a bullish move back up.

MF 6/13/22 Chart Review & Plan for 6/14/22

Day’s Volume: 7,622,414

Average 10 Day Volume: 28.08M

Day’s range: $0.2225-$0.2664

Closing Price: $0.2569

Short Interest: 0.49%

Analyst PT: High PT: $15.27, Low PT: $4.219, Average PT: $7.93

Catalysts:

  • Food shortage/inflation play.
  • Missfresh Announces Receipt of Nasdaq Notification Regarding Late Filing of Form 20-F. 5/24/22. View press release here.
  • Missfresh’s Retail Cloud Services Enabled Up To 20X Increase in Major Traditional Retailers’ Online Sales. 5/24/22. View press release here.
  • MissFresh Triples its Stock and Accelerates the Delivery Efforts to Meet Increasing Consumer Demand. 4/26//22. View press release here.
  • Sales of Missfresh’s Private Label Fresh Food Brand Surged 300% For Q4 2021. 3/30/22. View press release here.
  • Missfresh Expands China-wide Direct-Supply Vegetable Farm Network to Total More Than 1,300 Hectares. 3/2/22. View press release here.
  • Missfresh Successfully Launches Personalized Concierge Experience for High-value Customers, Doubling Relevant Monthly ARPU. 2/16/22. View press release here.

MF was unable to reclaim key support levels. Once futures flip green, watch this one for a reversal in the coming weeks. $0.30 levels needs to be reclaimed for a bullish move back up.

SIGA

SIGA 6/10/22 Chart Review & Plan for 6/13/22

SIGA fell $0.08 below my dip zone ($10.20-$10.45) at $10.12 (✓) premarket, moving +$1.13 (+10.18%) and hitting high of day (HOD) $11.15, fading into the close, and closing at $10.56. If there is a pullback, possible dip zone might be ($10.26-$10.45).

SIGA 6/13/22 Chart Review & Plan for 6/14/22

Day’s Volume: 4,473,597

Average 10 Day Volume: 25.20M

Day’s range: $9.61-$10.25

Closing Price: $9.71

Short Interest: 7.03%

Catalysts:

  • SIGA Receives Approval from the FDA for Intravenous (IV) Formulation of TPOXX® (tecovirimat). 5/19/22. View press release here.
  • New Contract Awarded by U.S. Department of Defense for the Procurement of up to Approximately $7.5 Million of Oral TPOXX®. 5/12/22. View press release here.
  • SIGA Reports Financial Results for Three Months Ended March 31, 2022. 5/5/22. View press release here.
  • SIGA Declares Special Dividend of $0.45 Per Share. 5/5/22. View press release here.

SIGA broke below the dip zone ($10.26-$10.45) along with the overall market being red. $10 levels need to be reclaimed, and then $11 levels need to be re-established.

VERU

VERU 6/10/22 Chart, Review, and Plan for 6/13/22

VERU broke well below my dip zone at ($13.28-$13.50), fading to a low of day $12.62, closing at $13.12. If there is a pullback, there may be a dip zone at ($12.60-$12.80).

VERU 6/13/22 Chart, Review, and Plan for 6/14/22

Day’s Volume: 3,733,865

Average 10 Day Volume: 9.45M

Day’s range: $12.18-$12.89

Closing price: $12.62

Short Interest: 34.39%

Analyst PT: $24-$55, Average PT: $36.50

In the last 3 months, 4 analysts offered 12 month price targets: high PT of $55, low PT of $24, and average PT of $36.50.

Catalysts:

  • Veru Submits Emergency Use Authorization (EUA) Application to U.S. FDA for Sabizabulin, its Novel, Oral Antiviral and Anti-Inflammatory Drug Candidate for Hospitalized COVID-19 Patients at High Risk for ARDS. 7/7/22. View the full press release here.
  • Tang Capital Partners, Lp Discloses 5.2% Passive Stake in Veru. 6/6/22.
  • Veru Announces Presentation of Final Positive Phase 1b/2 Clinical Trial Results for Sabizabulin in Metastatic Castration Resistant Prostate Cancer at the 2022 American Society of Clinical Oncology Annual Meeting. 6/6/22. View the full press release here.
  • Veru to Present Three Presentations at the 2022 American Society for Clinical Oncology Annual Meeting on June 3-7. 5/31/22. View the full press release here.
  • Veru to Participate in Fireside Chat at the Jefferies Healthcare Conference on June 8, 2022. 5/25/22. View the full press release here.
  • Veru Announces Appointment of Joel Batten to Lead U.S. Infectious Disease Franchise to Focus on Hospitalized COVID-19 Patients. 5/18/22 View the full press release here.
  • Veru to Present at the H.C. Wainwright Global Investment Conference on May 24th 2022. 5/17/22. View the full press release here.
  • Veru Reports Second Quarter Fiscal 2022 Results and Progress of Sabizabulin for COVID-19 Toward a Request for Emergency Use Authorization. 5/12/22. View the full press release here.
  • FDA States that Veru Should Submit Request for Emergency Use Authorization (EUA) Based on Positive Efficacy and Safety Data from the Phase 3 Clinical Study of Sabizabulin in Hospitalized COVID-19 Patients. 5/11/22. View the full press release here.
  • FDA Has Granted Veru a Pre-Emergency Use Authorization (EUA) Meeting Date for Positive Sabizabulin Phase 3 COVID-19 Study. 5/2/22. View the full press release here.
  • Veru Announces Oral Late-Breaking Presentation of Phase 2 Data of Sabizabulin for the Treatment of Hospitalized Severe COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome at the 32nd European Congress of Clinical Microbiology & Infectious Diseases. 4/25/22. View the full press release here.
  • Veru’s Novel COVID-19 Drug Candidate Reduces Deaths by 55% in Hospitalized Patients in Interim Analysis of Phase 3 Study; Independent Data Monitoring Committee Halts Study Early for Overwhelming Efficacy. 4/11/22. View the full press release here.

VERU broke well below my dip zone at ($12.60-$12.80) to $12.18, but it was able to reclaim my dip zone into the close, closing at $12.62. Watch for $13 to be reclaimed, and then climb back up one leg at a time.

RDBX

RDBX 6/10/22 Chart, Review, and Plan for 6/13/22

RDBX hit $0.01 below my dip zone ($9.40-$9.80) at $9.39 premarket (✓), and from there, it moved +$5.31 (+56.55%) and hit high of day (HOD) $14.70.If there is another pullback, the dip zone might be at ($13.11-$14.25). This has been a short setup for the last few months due to short interest for this being extremely high, so if all the big pullbacks get bought, there’s a chance we’ll go parabolic and break new highs soon. $16 levels need to be reclaimed, and a slow climb to $20-$30. Once an $18 base is formed, the next leg is $19-$20 levels, then $20-$27 levels, and possibly break all time highs from October 2021. We’ve set this multi-month swing up beautifully over the last few months.

RDBX 6/13/22 Chart, Review, and Plan for 6/14/22

Day’s Volume: 55,718,141

Average 10 Day Volume: 29.48M

Day’s range: $13.72-$18.20

Closing Price: $15.27

Short Interest: 38.56%

Catalysts:

  • POS AM. Post-effective amendment to an S-Type filing. 6/3/22. View filing here.
  • Redbox Entertainment Acquires North American Rights to WWII Action-Drama Come Out Fighting. 5/24/22. View press release here.
  • DEFA14A Sec-Filing Additional proxy soliciting materials – definitive. 5/13/22. View filing here.
  • 10-Q Quarterly report which provides a continuing view of a company’s financial position. 5/13/22. View filing here.
  • DEFA14A Additional proxy soliciting materials – definitive. 5/12/22. View filing here.
  • DEFA14A Additional proxy soliciting materials – definitive. 5/12/22. View filing here.
  • DEFA14A Additional proxy soliciting materials – definitive. 5/12/22. View filing here.
  • DEFA14A Additional proxy soliciting materials – definitive. 5/12/22. View filing here.
  • DEFA14A Additional proxy soliciting materials – definitive. 5/12/22. View filing here.
  • DEFA14A Additional proxy soliciting materials – definitive. 5/12/22. View filing here.
  • DEFA14A Additional proxy soliciting materials – definitive. 5/12/22. View filing here.
  • 8-K Report of unscheduled material events or corporate event. 5/11/22. View filing here.
  • 425 Filing of certain prospectuses and communications in connection with business combination transactions. 5/11/22. View filing here.
  • Chicken Soup for the Soul Entertainment to Acquire Redbox, Creating Premier Independent Entertainment Company. 5/11/22. View press release here.

RDBX hit my dip zone ($13.11-$14.25) at $13.73 premarket (✓), and from there, it moved +$4.47 (+32.56%) and hit high of day (HOD) $18.20.If there is another pullback, the dip zone might be at ($13.50-$14). SSR needs to get triggered at $13.74, for an SSR swing setup into Wednesday 6/15. This has been a short setup for the last few months due to short interest for this being extremely high, so if all the big pullbacks get bought, there’s a chance we’ll go parabolic and break new highs soon. $16 levels need to be reclaimed, and a slow climb to $20-$30. Once an $18 base is formed, the next leg is $19-$20 levels, then $20-$27 levels, and possibly break all time highs from October 2021. We’ve set this multi-month swing up beautifully over the last few months.

AGRI

AGRI 6/9/22 Chart, Review, and Plan for 6/10/22

AGRI has been moving in a downtrend. As I’ve mentioned previously, if any swing breaks its 5D/30D trend, respect stop losses. You can always re-enter again when it has the right setup. AGRI needs to reclaim $2.50 levels before moving back up again.

AGRI 6/13/22 Chart, Review, and Plan for 6/14/22

Day’s Volume: 8,395,205

Average 10 Day Volume: 1.79M

Day’s range: $1.85-$2.66

Closing Price: $2.32

Short Interest: 0.42%

Analyst PT: $5

Catalysts:

  • “AgriForce to Present at the Food & AgTech Conference on June 8th.” 6/2/22. View full press release here.
  • “AgriForce to Present at the H.C. Wainwright Global Investment Conference on May 25th” 5/23/22. View full press release here.
  • “AgriFORCE Growing Systems Completes Acquisition of Food Production & Processing IP from Manna Nutritional Group (MNG)” 5/18/22. View full press release here.
  • “Quarterly report pursuant to Section 13 or 15(d) (10-Q).” 5/16/22. View sec-filing here.
  • “AgriFORCE Growing Systems Provides Update on Acquisition of Delphy, a Leading European Agriculture/Horticulture and AgTech Consulting Firm.” 5/12/22. View the full press release here.
  • AgriFORCE is presenting at “Microcap Rodeo’s Spring into Action Best Ideas Virtual Conference on May 17th.” Management is scheduled to present on Tuesday, May 17, 2022 at 3:00 p.m. ET. The presentation will be webcast live and available for replay https://www.webcaster4.com/Webcast/Page/2882/45580.  5/11/22. View the full press release here.
  • Agriculture stocks are a very hot sector due to food shortage, food inflation, and plant/farm explosions. Agriforce is one of the main leaders according to what’s trending across discords and most mentions.

AGRI hit low of day $1.85 and from there it hit high of day $2.66. If there is another pullback, it may be at ($2.08-2.20). AGRI needs to reclaim $2.50 levels to re-establish support levels before moving back up again.

AMD

AMD 6/9/22 Chart Review & Plan for 6/10/22

AMD was $1.72 above my dip zone ($98-$100) at $101.72 and moved $2.22 (+2.18%) to high of day $103.94. It faded to a low of day $96 after hours. If there is a pullback, the dip zone might be at ($96-$97.50).

AMD 6/13/22 Chart Review & Plan for 6/14/22

Day’s Volume: 98,148,812

Average 10 Day Volume: 102.70M

Day’s range: $86.64-$92.03

Closing Price: $86.99

Short Interest: 2.07%

Analyst PT: High PT: $200, Low PT: $97, Average PT: $137.91

Catalysts:

  • AMD Details Strategy to Drive Next Phase of Growth Across $300 Billion Market for High-Performance and Adaptive Computing Solutions. 6/9/22. View press release here.
  • AMD Announces Pricing of Senior Notes Offering. 6/7/22. View press release here.
  • AMD Announces Senior Notes Offering. 6/7/22. View press release here.
  • AMD to Host Financial Analyst Day on June 9, 2022. 6/2/22. View press release here.
  • AMD Expands High Performance Compute Fund to Aid Researchers Solving the World’s Toughest Challenges. 6/1/22. View press release here.
  • World’s First Exascale Supercomputer Powered by AMD EPYC™ Processors and AMD Instinct™ Accelerators. 5/30/22. View press release here.
  • AMD Instinct™ MI200 Adopted for Large-Scale AI Training in Microsoft Azure. 5/26/22. View press release here.
  • AMD Expands Data Center Solutions Capabilities with Acquisition of Pensando. 5/26/22. View press release here.
  • AMD Expands Confidential Computing Presence on Google Cloud. 5/25/22. View press release here.
  • AMD Showcases Industry-Leading Gaming, Commercial, and Mainstream PC Technologies at COMPUTEX 2022. 5/23/22. View press release here.
  • AMD Chair and CEO Dr. Lisa Su to Keynote at COMPUTEX 2022. 5/20/22. View press release here.
  • Statement of changes in beneficial ownership of securities. 5/19/22 View press release here.
  • AMD Robotics Starter Kit Kick-Starts the Intelligent Factory of the Future. 5/17/22. View press release here.
  • AMD and Qualcomm Collaborate to Optimize FastConnect Connectivity Solutions for AMD Ryzen Processors. 5/17/22. View press release here.
  • AMD Enables 4G/5G Radio Access Network Solutions to Support Meta Connectivity Evenstar Program. 5/11/22. View press release here.
  • AMD Announces Three New Radeon RX 6000 Series Graphics Cards and First Games Adding Support for AMD FidelityFX Super Resolution 2.0. 5/10/22. View press release here.
  • New AMD Ryzen 5000 C-Series Processors Bring Leadership Performance and All-Day Battery Life to Chrome OS. 5/5/22. View press release here.
  • AMD Reports First Quarter 2022 Financial Results. 5/3/22. View press release here.

On 6/10/22, AMD broke key support levels, which is why I didn’t give dip zones. Watch futures to flip green; if it does, watch AMD for the move back up. We are sitting at the last dip zone. We do NOT want AMD to break below $84. If it does, it may see $77-$80 levels, and we don’t want that.

Others to Watch/Trending

Monitor volume for these in the coming weeks. Movement may be due to Analyst Upgrades, whales being spotted, or trending due to catalysts. Do your due diligence first.

  1. AMZN
  2. TSLA
  3. RBLX
  4. IGEX
  5. HILS
  6. NILE
  7. GMVD
  8. OPTN
  9. CYN
  10. KAVL
  11. EMBK
  12. SLNO
  13. CLVS
  14. ORCL
  15. CISO
  16. TOP
  17. MDVL
  18. CYRN
  19. LLY
  20. MTCH

Oil/Gas Stocks to Watch

I accumulate my oil stocks while crude oil is red. It’s easier than chasing once it reverses back up. Watch for a reversal heading into next weekend as we approach Father’s Day weekend, Graduation, and summer vacation. The sentiment across the board is that gas and oil will rise higher over the summer. If crude oil flips red, that’s the best time to start accumulating to build a position to swing.

  1. INDO – 52.29% SI
  2. VTNR – 20.38% SI
  3. IMPP – 14.54% SI
  4. HUSA -12.41% SI
  5. ENSV – 3.54% SI
  6. MARPS – 2.91% SI
  7. MXC – 1.94% SI
  8. SNMP – 47.09%
  9. USWS – 9.14% SI
  10. CEI – 6.56% SI
  11. XOM – 1.21% SI
  12. CVX – 1.19% SI

Food Shortage/Agriculture Stocks to Watch

Monitor the news if trading any of these. Anytime the news mention food plant explosion, farm/crop fires, rising food price, etc. watch these for movement. Volume is everything, so follow the volume if you notice abnormal volume pour in. I like to trade the leaders and avoid weaker sympathy plays.

  1. AGRI
  2. VGFC
  3. MF
  4. RIBT
  5. SVFD
  6. WEAT
  7. EDBL
  8. FPI
  9. CAG
  10. LAND
  11. ANDE
  12. GIS
  13. GO
  14. K
  15. SEB
  16. ADM

Earnings

If entering the day of, I like to keep them as day trades unless there’s a clear direction of whether it should be a short or long swing. Unless I’m confident in the earnings result, I do not like to hold through earnings. For tech large caps, even if earnings are mediocre, as long as guidance is strong; it tends to see a bullish move.

Tuesday 6/14/22

  1. LICY
  2. FERG
  3. HITI
  4. IRNT
  5. CXM
  6. RFIL
  7. KSPN

Wednesday 6/15/22

  1. MMMB
  2. WDH
  3. WLY

Thursday 6/16/22

  1. KR
  2. CMC
  3. JBL

Friday 6/17/22

  1. ALYA

Many have requested I charge a service fee, however, I won’t be doing that. For those wanting to open up a new account, you can get free stocks when you open a Webull Account with my referral link that’s on the sidebar & homepage. If you would like to help me pay it forward to help others in need, you’re welcome to donate to the link below. Every bit helps me to help others in need as I do spend hours on my research and do not receive compensation via advertising, sponsorships, etc. I truly appreciate you taking the time to read.

-Cheers

Disclaimer : This should not be considered investment advice, and should not be used to make investment decisions. Do not buy or sell any stock without conducting your own due diligence. Information on eyelovegains.com is opinionated and should be considered for information purposes only. No stock exchange anywhere has approved or disapproved the information contained herein. There is no express or implied solicitation to buy or sell securities. The charts and data provided here are not meant for investment purposes and only serve as examples. We are not liable for any losses you may endure from the buying and selling of stocks or securities within your accounts.

Tags:

Eye Love Gains

Anna is the face behind Eye Love Gains. Her passion for helping Entrepreneurs, Small Business Owners, Traders, and those struggling to rebuild their lives is the key motivation behind eyelovegains.com.

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *